NPHCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
NUTRA PHARMA CORP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$0.00+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $806.69K
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2010 Ended Jun 30, 2010 | Aug 6, 2010 | During market hours | – | – | – |
| Q4 FY2009 Ended Dec 31, 2009 | Feb 2, 2010 | Before market open | – | – | – |
Press releases
Announcements Nutra Pharma filed with the SEC
Pharma Corp. Reaches Settlement with SEC
Executive or director change · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Park of Commerce Blvd ♦ Suite 1B
Executive or director change · Regulation FD disclosure · Other events · EX-99.2 to Form 8-K